Amol Akhade/hiranandanihospital.org
Mar 26, 2025, 03:36
Amol Akhade: Immune Checkpoint Inhibitors are under phase 3 trial in China
Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:
“Made In China. Approved in China. Under phase 3 trial in China. Immune Checkpoint inhibitors. Do feel free to add any other drugs in both of these category if u know.”
More posts featuring Amol Akhade.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34